Zegalogue

Chemical Namedasiglucagon
Dosage FormInjection (subcutaneous; 0.6 mg/0.6 mL)
Drug ClassMiscellaneous
SystemBlood
CompanyZealand Pharma A/S
Approval Year2021

Indication

  • Indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above.
Last updated on 3/26/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Zegalogue (dasiglucagon) Prescribing Information2021Zealand Pharma A/S, 2860 Søborg, Denmark